MCID: HRD010
MIFTS: 62

Hereditary Spastic Paraplegia malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Gastrointestinal diseases, Bone diseases, Metabolic diseases, Mental diseases

Aliases & Classifications for Hereditary Spastic Paraplegia

About this section

Aliases & Descriptions for Hereditary Spastic Paraplegia:

Name: Hereditary Spastic Paraplegia 32 10 21 45 22 46 12
Spastic Paraplegia 10 47 24 65
Spastic Paraplegia, Hereditary 36 24 65
Familial Spastic Paraplegia 10 21 22
Hereditary Spastic Paraparesis 21 22
Strumpell-Lorrain Syndrome 21 22
 
Hsp 45 22
Spastic Paraplegia Hereditary 47
Familial Spastic Paraparesis 45
Hsmn V 10
Fsp 45

Classifications:



External Ids:

Disease Ontology10 DOID:2476
ICD1027 G11.4, G82.1
ICD9CM29 334.1
MeSH36 D015419
UMLS65 C0037773, C0037772

Summaries for Hereditary Spastic Paraplegia

About this section
NIH Rare Diseases:45 Hereditary spastic paraplegia (hsp) is a group of hereditary, degenerative, neurological disorders that primarily affect the upper motor neurons. upper motor neurons in the brain and spinal cord deliver signals to the lower motor neurons, which in turn, carry messages to the muscles. in hereditary spastic paraplegia, upper motor neurons slowly degenerate so the muscles do not receive the correct messages, causing progressive spasticity (increased muscle tone/stiffness) and weakness of the legs. this leads to difficulty walking. as degeneration continues, symptoms worsen. if only the lower body is affected, hsp is classified as uncomplicated or pure. hsp is classified as complicated or complex if other systems are involved. in these cases, additional symptoms, including impaired vision, ataxia, epilepsy, cognitive impairment, peripheral neuropathy, and/or deafness, occur. the different forms of hsp are caused by mutations in different genes. inheritance varies. there are no specific treatments to prevent, slow, or reverse hsp. individual symptoms may be treated with medications and/or physical therapy.  last updated: 4/24/2016

MalaCards based summary: Hereditary Spastic Paraplegia, also known as spastic paraplegia, is related to spastic paraplegia 4 and spastic paraplegia 8, and has symptoms including hypertonia, gait disturbance and hemiplegia/hemiparesis. An important gene associated with Hereditary Spastic Paraplegia is KIF1A (Kinesin Family Member 1A), and among its related pathways is Endocytosis. Affiliated tissues include skeletal muscle, brain and eye, and related mouse phenotypes are nervous system and reproductive system.

Disease Ontology:10 A paraplegia that is characterized by progressive stiffness and contraction (spasticity) in the lower limbs.

NINDS:46 Hereditary spastic paraplegia (HSP), also called familial spastic paraparesis (FSP), refers to a group of inherited disorders that are characterized by progressive weakness and spasticity (stiffness) of the legs. Early in the disease course, there may be mild gait difficulties and stiffness. These symptoms typically slowly progress so that eventually individuals with HSP may require the assistance of a cane, walker, or wheelchair. Though the primary features of "pure" HSP are progressive lower limb spasticity and weakness, complicated forms may be accompanied by other symptoms. These additional symptoms include impaired vision due to cataracts and problems with the optic nerve and retina of the eye, ataxia (lack of muscle coordination), epilepsy, cognitive impairment, peripheral neuropathy, and deafness. The diagnosis of HSP is primarily by neurological examination and testing to rule out other disorders. Brain MRI abnormalities, such as a thin corpus callosum, may be seen in some of the complicated forms of HSP.

Wikipedia:68 Hereditary spastic paraplegia (HSP), also known as hereditary spastic paraparesis, familial spastic... more...

GeneReviews summary for NBK1509

Related Diseases for Hereditary Spastic Paraplegia

About this section

Diseases in the Spastic Paraplegia 3a family:

Spastic Paraplegia 29, Autosomal Dominant Spastic Paraplegia 63
Spastic Paraplegia 47, Autosomal Recessive Spastic Paraplegia 23
Spastic Paraplegia 44, Autosomal Recessive Spastic Paraplegia 74, Autosomal Recessive
Spastic Paraplegia 4, Autosomal Dominant Spastic Paraplegia 31, Autosomal Dominant
Spastic Paraplegia 13, Autosomal Dominant Spastic Paraplegia 30, Autosomal Recessive
Spastic Paraplegia 57, Autosomal Recessive Spastic Paraplegia 42, Autosomal Dominant
Spastic Paraplegia 14, Autosomal Recessive Spastic Paraplegia 38, Autosomal Dominant
Spastic Paraplegia 56, Autosomal Recessive Spastic Paraplegia 72, Autosomal Recessive
Spastic Paraplegia 25, Autosomal Recessive Spastic Paraplegia 48, Autosomal Recessive
Spastic Paraplegia 50, Autosomal Recessive Spastic Paraplegia 53, Autosomal Recessive
Spastic Paraplegia 37, Autosomal Dominant Spastic Paraplegia 54, Autosomal Recessive
Spastic Paraplegia 18, Autosomal Recessive Spastic Paraplegia 5a, Autosomal Recessive
Spastic Paraplegia 8, Autosomal Dominant Spastic Paraplegia 46, Autosomal Recessive
Spastic Paraplegia 19, Autosomal Dominant Spastic Paraplegia 27, Autosomal Recessive
Spastic Paraplegia 64, Autosomal Recessive Spastic Paraplegia 33, Autosomal Dominant
Spastic Paraplegia 9a, Autosomal Dominant Spastic Paraplegia 9b, Autosomal Recessive
Spastic Paraplegia 45, Autosomal Recessive Spastic Paraplegia 41, Autosomal Dominant
Spastic Paraplegia 26, Autosomal Recessive Spastic Paraplegia 10, Autosomal Dominant
Spastic Paraplegia 36, Autosomal Dominant Spastic Paraplegia 55, Autosomal Recessive
Spastic Paraplegia 24, Autosomal Recessive Spastic Paraplegia 3a, Autosomal Dominant
Spastic Paraplegia 52, Autosomal Recessive Spastic Paraplegia 32, Autosomal Recessive
Spastic Paraplegia 28, Autosomal Recessive Spastic Paraplegia 15, Autosomal Recessive
Spastic Paraplegia 49, Autosomal Recessive Spastic Paraplegia 6, Autosomal Dominant
Spastic Paraplegia 11, Autosomal Recessive Spastic Paraplegia 51, Autosomal Recessive
Spastic Paraplegia 61, Autosomal Recessive Spastic Paraplegia 35, Autosomal Recessive
Spastic Paraplegia 7, Autosomal Recessive Spastic Paraplegia 39, Autosomal Recessive
Spastic Paraplegia 43, Autosomal Recessive Spastic Paraplegia 12, Autosomal Dominant
Spastic Paraplegia 73, Autosomal Dominant hereditary spastic paraplegia
Spastic Paraplegia 4 Spastic Paraplegia 7
Spastic Paraplegia 8 Spastic Paraplegia 11
Spastic Paraplegia 1 Spastic Paraplegia 10
Spastic Paraplegia 12 Spastic Paraplegia 13
Spastic Paraplegia 14 Spastic Paraplegia 15
Spastic Paraplegia 16 Spastic Paraplegia 17
Spastic Paraplegia 18 Spastic Paraplegia 19
Spastic Paraplegia 2 Spastic Paraplegia 24
Spastic Paraplegia 25 Spastic Paraplegia 26
Spastic Paraplegia 29 Spastic Paraplegia 3
Spastic Paraplegia 31 Spastic Paraplegia 32
Spastic Paraplegia 39 Spastic Paraplegia 51
Spastic Paraplegia 5a Spastic Paraplegia 5b
Spastic Paraplegia 6 Spastic Paraplegia 9
Spastic Paraplegia 28 Spastic Paraplegia 30
Spastic Paraplegia 33 Spastic Paraplegia 35
Spastic Paraplegia 42 Spastic Paraplegia 43
Spastic Paraplegia 45 Spastic Paraplegia 46
Spastic Paraplegia 47 Spastic Paraplegia 48
Spastic Paraplegia 49 Spastic Paraplegia 50
Spastic Paraplegia 52 Spastic Paraplegia 53
Spastic Paraplegia 54 Spastic Paraplegia 55
Spastic Paraplegia 56 Spastic Paraplegia 57
Spastic Paraplegia 61 Spastic Paraplegia 64
Spastic Paraplegia 66 Spastic Paraplegia 72
Spastic Paraplegia 75 Spastic Paraplegia 44
Autosomal Recessive Spastic Paraplegia Type 62 Autosomal Recessive Spastic Paraplegia Type 60
Autosomal Recessive Spastic Paraplegia Type 59 Autosomal Recessive Spastic Paraplegia Type 68
Autosomal Recessive Spastic Paraplegia Type 69 Autosomal Recessive Spastic Paraplegia Type 70
Autosomal Recessive Spastic Paraplegia Type 71 Autosomal Recessive Spastic Paraplegia Type 66
Autosomal Recessive Spastic Paraplegia Type 67 Autosomal Spastic Paraplegia Type 72
Autosomal Recessive Spastic Paraplegia Type 58 Autosomal Dominant Spastic Paraplegia Type 9

Diseases related to Hereditary Spastic Paraplegia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 415)
idRelated DiseaseScoreTop Affiliating Genes
1spastic paraplegia 433.7ATL1, SPAST
2spastic paraplegia 833.0KIF1A, SPG7
3spastic paraplegia 3132.0ATL1, KIF1A
4hereditary spastic paraplegia - autosomal dominant inheritance12.4
5hereditary spastic paraplegia - autosomal recessive inheritance12.4
6hereditary spastic paraplegia - x-linked inheritance12.4
7hereditary spastic paraplegia - maternal inheritance12.4
8spg11-related hereditary spastic paraplegia with thin corpus callosum12.4
9spastic paraplegia 712.3
10troyer syndrome12.2
11spastic paraplegia 1112.2
12masa syndrome12.1
13spastic paraplegia 212.0
14infantile-onset ascending hereditary spastic paralysis11.9
15wells-jankovic syndrome11.5
16mast syndrome11.2
17spastic paraplegia 1511.2
18spastic paraplegia 5a, autosomal recessive11.1
19spastic paraplegia 3a, autosomal dominant11.1
20silver spastic paraplegia syndrome10.7
21spastic paraplegia 3a10.7
22thyroiditis10.5
23neuronitis10.5
24spastic paraplegia 29, autosomal dominant10.5
25spastic paraplegia 6310.5
26spastic paraplegia 2310.5
27spastic paraplegia 13, autosomal dominant10.5
28spastic ataxia 3, autosomal recessive10.5
29spastic paraplegia 30, autosomal recessive10.5
30spastic paraplegia 57, autosomal recessive10.5
31spastic paraplegia 42, autosomal dominant10.5
32spastic paraplegia 14, autosomal recessive10.5
33spastic paraplegia 38, autosomal dominant10.5
34spastic paraplegia 56, autosomal recessive10.5
35spastic paraplegia 25, autosomal recessive10.5
36spastic paraplegia 48, autosomal recessive10.5
37spastic paraplegia 53, autosomal recessive10.5
38spastic paraplegia 37, autosomal dominant10.5
39spastic paraplegia 54, autosomal recessive10.5
40spastic paraplegia 18, autosomal recessive10.5
41spastic paraplegia 46, autosomal recessive10.5
42spastic paraplegia 19, autosomal dominant10.5
43ataxia, spastic, 410.5
44spastic paraplegia 27, autosomal recessive10.5
45spastic paraplegia 64, autosomal recessive10.5
46spastic paraplegia 45, autosomal recessive10.5
47spastic paraplegia 41, autosomal dominant10.5
48spastic paraplegia, optic atrophy, and neuropathy10.5
49spastic ataxia 1, autosomal dominant10.5
50spastic paraplegia 26, autosomal recessive10.5

Graphical network of the top 20 diseases related to Hereditary Spastic Paraplegia:



Diseases related to hereditary spastic paraplegia

Symptoms for Hereditary Spastic Paraplegia

About this section

HPO human phenotypes related to Hereditary Spastic Paraplegia:

(show all 6)
id Description Frequency HPO Source Accession
1 hypertonia hallmark (90%) HP:0001276
2 gait disturbance hallmark (90%) HP:0001288
3 hemiplegia/hemiparesis hallmark (90%) HP:0004374
4 impaired pain sensation hallmark (90%) HP:0007328
5 incoordination typical (50%) HP:0002311
6 finger syndactyly occasional (7.5%) HP:0006101

Drugs & Therapeutics for Hereditary Spastic Paraplegia

About this section

Drugs for Hereditary Spastic Paraplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AcetylcholineexperimentalPhase 2, Phase 368951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
2Cholinergic AgentsPhase 2, Phase 33243
3Neurotransmitter AgentsPhase 2, Phase 314795
4Botulinum ToxinsPhase 2, Phase 3616
5
chenodeoxycholic acidapprovedPhase 225474-25-910133
Synonyms:
(+)-chenodeoxycholate
(+)-chenodeoxycholic acid
(3a,5b,7a)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7a)-3,7-dihydroxy-cholan-24-oic acid
3a,7a-Dihydroxy-5b,14a,17b-cholanate
3a,7a-Dihydroxy-5b,14a,17b-cholanic acid
3a,7a-Dihydroxy-5b-cholan-24-oate
3a,7a-Dihydroxy-5b-cholan-24-oic acid
3a,7a-Dihydroxy-5b-cholanate
3a,7a-Dihydroxy-5b-cholanic acid
3alpha,7alpha-Dihydroxy-5beta-cholanic acid
7a-Hydroxy-desoxycholsaeure
 
7alpha-Hydroxylithocholic acid
Anthropodeoxycholic acid
Anthropodesoxycholic acid
CDCA
Chenic acid
Chenix
Chenocholic acid
Chenodal
Chenodeoxycholate
Chenodeoxycholic acid
Chenodesoxycholic acid
Chenodesoxycholsaeure
Chenodiol
Gallodesoxycholic acid
6
Resveratrolexperimental, investigationalPhase 2105501-36-0, 955365-80-724856436, 445154
Synonyms:
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(p-Hydroxystyryl)resorcinol
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol
(E)-resveratrol
 
3,4',5-Stilbenetriol
3,4',5-Trihydroxystilbene
3,4',5-trihydroxy-stilbene
MK-1775
trans-3,4',5 - Trihydroxystilbene
trans-3,4',5-trihydroxystilbene
trans-Resveratrol
7Gastrointestinal AgentsPhase 26401
8LaxativesPhase 2344
9Protective AgentsPhase 25651
10CatharticsPhase 2344
11Platelet Aggregation InhibitorsPhase 21935
12Peripheral Nervous System AgentsPhase 218510
13Atorvastatin CalciumPhase 2714134523-03-8
14Antirheumatic AgentsPhase 28496
15AnalgesicsPhase 29358
16Anti-Inflammatory AgentsPhase 28478
17Analgesics, Non-NarcoticPhase 25184
18Anti-Inflammatory Agents, Non-SteroidalPhase 23549
19AntioxidantsPhase 22442
20Antineoplastic Agents, PhytogenicPhase 24294
21
Creatineapproved, nutraceutical11057-00-1586
Synonyms:
((amino(Imino)methyl)(methyl)amino)acetic acid
((amino(imino)methyl)(methyl)amino)acetate
((amino(imino)methyl)(methyl)amino)acetic acid
(N-methylcarbamimidamido)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(α-methylguanido)acetic acid
Cosmocair C 100
Creatin
Creatine
Creatine hydrate
Kreatin
 
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-Methyl-Glycine
N-(aminoiminomethyl)-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
Phosphagen
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetic acid
22
Cholineapproved, nutraceutical13062-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
23N-Methylaspartate98
24Aspartic AcidNutraceutical98

Interventional clinical trials:

idNameStatusNCT IDPhase
1Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic ParaplegiaNot yet recruitingNCT02604186Phase 2, Phase 3
2Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5Active, not recruitingNCT02314208Phase 2
3Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral SclerosisCompletedNCT00023075
4Genetic and Physical Study of Childhood Nerve and Muscle DisordersRecruitingNCT01568658
5Phenotype, Genotype & Biomarkers in ALS and Related DisordersRecruitingNCT02327845

Search NIH Clinical Center for Hereditary Spastic Paraplegia


Cochrane evidence based reviews: spastic paraplegia, hereditary

Genetic Tests for Hereditary Spastic Paraplegia

About this section

Genetic tests related to Hereditary Spastic Paraplegia:

id Genetic test Affiliating Genes
1 Hereditary Spastic Paraplegia22

Anatomical Context for Hereditary Spastic Paraplegia

About this section

MalaCards organs/tissues related to Hereditary Spastic Paraplegia:

33
Skeletal muscle, Brain, Eye, Testes, Spinal cord, Retina, Myeloid

Animal Models for Hereditary Spastic Paraplegia or affiliated genes

About this section

MGI Mouse Phenotypes related to Hereditary Spastic Paraplegia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00036317.8AFG3L2, ALS2, HSPD1, KIF1A, KIF5A, L1CAM
2MP:00053896.8BSCL2, CYP7B1, DDHD1, HSPD1, KATNB1, L1CAM
3MP:00053866.2AFG3L2, ALS2, ATL1, BSCL2, CYP7B1, HSPD1

Publications for Hereditary Spastic Paraplegia

About this section

Articles related to Hereditary Spastic Paraplegia:

(show top 50)    (show all 470)
idTitleAuthorsYear
1
An Unusual Bone Metastasis Mimicking SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis) Syndrome on Bone Scintigraphy. (26505860)
2015
2
Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease. (25403865)
2014
3
Acute myocardial infarction in Kabuki syndrome: chance occurrence or a novel risk factor for premature atherosclerosis? (25065336)
2014
4
Comparison of Prognosis in Unrecognized Versus Recognized Myocardial Infarction in Men Versus Women >55 Years of Age (from the Rotterdam Study). (24216125)
2014
5
MicroRNA-21 Promotes Cell Growth and Migration by Targeting Programmed Cell Death 4 Gene in Kazakh's Esophageal Squamous Cell Carcinoma. (25400316)
2014
6
Increased autotaxin activity in multiple sclerosis. (24984830)
2014
7
Modeling the binding mechanism of Alzheimer's AI^1-42 to nicotinic acetylcholine receptors based on similarity with snake I+-neurotoxins. (23022323)
2013
8
Corneal ectasia after LASIK in a patient with normal scheimpflug evaluation but a high Ectasia Risk Score. (23952843)
2013
9
Concomitant human infections with 2 cowpox virus strains in related cases, France, 2011. (24274113)
2013
10
DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays. (23010602)
2013
11
Studies of microparticles in patients with the antiphospholipid syndrome (APS). (22635239)
2012
12
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. (22566498)
2012
13
Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin's disease: a review. (21326655)
2011
14
Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children. (20711594)
2011
15
Regulation of B cell activating factor (BAFF) receptor expression by NF-I9B signaling in rheumatoid arthritis B cells. (21515993)
2011
16
The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression. (22028862)
2011
17
Unusual presentation in Axenfeld-Rieger syndrome. (21666320)
2011
18
Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite. (19179285)
2009
19
The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations. (19804909)
2009
20
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. (19607716)
2009
21
Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke. (19934565)
2009
22
The Wnt antagonists Frzb-1 and Crescent locally regulate basement membrane dissolution in the developing primary mouth. (19224982)
2009
23
Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. (18684106)
2008
24
Nuclear beta-arrestin1 functions as a scaffold for the dephosphorylation of STAT1 and moderates the antiviral activity of IFN-gamma. (18775329)
2008
25
The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1. (17912454)
2007
26
Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. (17426098)
2007
27
A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. (16606690)
2006
28
Peripheral protein adsorption to lipid-water interfaces: the free area theory. (16150972)
2005
29
Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. (16079302)
2005
30
Block of human NaV1.5 sodium channels by novel alpha-hydroxyphenylamide analogues of phenytoin. (15066664)
2004
31
Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. (15240658)
2004
32
Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. (15333598)
2004
33
Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. (11857353)
2002
34
SMN tudor domain structure and its interaction with the Sm proteins. (11135666)
2001
35
The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). (11289049)
2001
36
Regulation of Na+-K+-ATPase: effect of Mg and Ca ions]. (11642044)
2001
37
The MNS blood group antigens, Vr (MNS12) and Mt(a) (MNS14), each arise from an amino acid substitution on glycophorin A. (10729812)
2000
38
Multicenter study of paroxysmal dyskinesias in Japan--clinical and pedigree analysis. (10435504)
1999
39
Structure and evolution of the human SPRR3 gene: implications for function and regulation. (9889002)
1999
40
Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. (9519750)
1998
41
Frequent N addition and clonal relatedness among immunoglobulin lambda light chains expressed in rheumatoid arthritis synovia and PBL, and the influence of V lambda gene segment utilization on CDR3 length. (9742508)
1998
42
Histopathological and prognostic evaluation of immunohistochemical findings in colorectal cancer. (9342635)
1997
43
Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas TAcmoins sur 'Infarctus du Myocarde. (8728314)
1996
44
Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. (7914688)
1994
45
Antenatal diagnosis and outcome in hydrops fetalis. (8487153)
1993
46
Early total thyroidectomy in patients with multiple endocrine neoplasia IIb syndrome. (2573160)
1989
47
Public health aspects of opisthorchiasis in Thailand. (6542380)
1984
48
Isolation and amino acid sequences of proline-rich peptides of human whole saliva. (479131)
1979
49
A malignant bronchial adenoma presenting as a carcinoid syndrome. (13994698)
1963
50

Variations for Hereditary Spastic Paraplegia

About this section

Clinvar genetic disease variations for Hereditary Spastic Paraplegia:

5
id Gene Variation Type Significance SNP ID Assembly Location
1KIF1ANM_001244008.1(KIF1A): c.206C> T (p.Ser69Leu)single nucleotide variantPathogenicrs786200949GRCh37Chr 2, 241727625: 241727625

Expression for genes affiliated with Hereditary Spastic Paraplegia

About this section
Search GEO for disease gene expression data for Hereditary Spastic Paraplegia.

Pathways for genes affiliated with Hereditary Spastic Paraplegia

About this section

Pathways related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.3KIAA0196, KIF5A, SPG20, ZFYVE27

GO Terms for genes affiliated with Hereditary Spastic Paraplegia

About this section

Cellular components related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1midbodyGO:003049610.0SPAST, SPG20
2early endosomeGO:00057699.1ALS2, HSPD1, KIAA0196, NIPA1

Biological processes related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1anterograde axonal transportGO:000808910.2SPAST, SPG7
2positive regulation of microtubule depolymerizationGO:00311179.8KATNB1, SPAST
3myelinationGO:00425529.8AFG3L2, PLP1
4lipid particle organizationGO:00343899.7BSCL2, SPG20

Molecular functions related to Hereditary Spastic Paraplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1microtubule bindingGO:00080179.5KATNB1, KIF1A

Sources for Hereditary Spastic Paraplegia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet